Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,635 | 12,096 | 8,702 | 8,142 | 9,101 |
| Marketable Securities | N/A | N/A | 3,050 | 7,809 | 6,906 |
| Other current assets | 375 | 631 | 547 | 425 | 648 |
| TOTAL | $10,010 | $12,727 | $12,299 | $16,376 | $16,655 |
| Non-Current Assets | |||||
| PPE Net | 33 | 37 | 42 | 48 | 54 |
| Other Non-Current Assets | 24 | 24 | 24 | 497 | 587 |
| TOTAL | $57 | $61 | $66 | $545 | $641 |
| Total Assets | $10,067 | $12,788 | $12,365 | $16,921 | $17,296 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 406 | 772 | 622 | 1,237 | 1,072 |
| Accrued Expenses | 654 | 947 | 1,448 | 1,307 | 1,447 |
| TOTAL | $1,060 | $1,719 | $2,070 | $2,544 | $2,519 |
| Non-Current Liabilities | |||||
| TOTAL | $9 | $15 | $20 | $25 | $30 |
| Total Liabilities | $1,069 | $1,734 | $2,090 | $2,569 | $2,549 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 64 | 64 | 64 | 54 | 54 |
| Common Shares | 14 | 14 | 12 | 12 | 10 |
| Retained earnings | -135,852 | -133,736 | -131,001 | -126,804 | -122,371 |
| Other shareholders' equity | 0 | 0 | -2 | -3 | -5 |
| TOTAL | $8,998 | $11,054 | $10,275 | $14,352 | $14,747 |
| Total Liabilities And Equity | $10,067 | $12,788 | $12,365 | $16,921 | $17,296 |